Toronto Cardiac Tumour Conference


 

Neoadjuvant Chemotherapy: Evidence, Rationale and Approach. Is Combination Chemotherapy preferred over Single Agent Chemo? Is a Combination of Adriamycin and Ifosfamide the Preffered First Line Agent?

22 views
September 3, 2020
0 Comments
Login to view comments. Click here to Login
2020